About
Larry G. Cabral, Ph.D. is a scientist-founder and biotechnology executive. He is listed as Co-Founder, CEO, and a board member of Lyceum Pharmaceuticals, a company focused on drug discovery for chronic and age-related disease using evolutionary biology, omics, and AI. Earlier published work places him in evolutionary biology research, including a 2014 PLOS ONE paper with a then-current address at the University of California, Irvine.
Areas of interest
longevityagingbiotechdrug discoveryomicsAIevolutionary biology